Skip to main content
Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology 7/2015

01.07.2015 | Inflammatory Disorders

Clinical manifestation of Fuchs uveitis syndrome in childhood

verfasst von: Christoph Tappeiner, Jens Dreesbach, Martin Roesel, Carsten Heinz, Arnd Heiligenhaus

Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology | Ausgabe 7/2015

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The aim of this study was to describe clinical signs and complications of Fuchs uveitis syndrome (FUS) with onset in childhood.

Methods

Ophthalmologic findings and complications in patients with FUS becoming manifest before the age of 16 years were analyzed in a retrospective study at a tertiary referral uveitis center. Inclusion criteria were the presence of pathognomonic FUS findings at any time point and exclusion of any systemic immune-mediated or infectious disease.

Results

A total of 23 patients (male = 16, female = 7) with juvenile FUS (unilateral n = 20, bilateral n = 3 patients) were included in the study. Mean ages at uveitis and FUS diagnosis were 12.0 ± 4.2 and 22.7 ± 10.7 years, respectively. In six patients, inflammation was noted at age ≤ 7 years. The following inflammatory signs were observed in a total of 26 eyes: ≤ 1+ anterior chamber cell grade (n = 26), vitreous cells (n = 24), fine keratic precipitates (KPs; n = 23), stellate KPs (n = 11), mutton-fat KPs (n = 23), diffuse (n = 24) or inferior (n = 8) distribution of KPs, Koeppe nodules (n = 10), and iris heterochromia (n = 14). A representative subgroup of patients (n = 5) is shown who presented with non-specific clinical signs in the beginning and in whom typical FUS signs became manifest only at a later stage. Secondary complications such as cataract (n = 19), ocular hypertension (n = 3), or glaucomatous disc damage (n = 2) were found after a mean uveitis duration of 11.6, 19.5, and 20.3 years, respectively.

Conclusion

FUS may begin in early childhood, and the characteristic findings may not be present at onset of disease. The diagnosis is often delayed for years, occasionally with the consequence of overtreatment with anti-inflammatory drugs.
Literatur
2.
Zurück zum Zitat Mohamed Q, Zamir E (2005) Update on Fuchs’ uveitis syndrome. Curr Opin Ophthalmol 16:356–363PubMedCrossRef Mohamed Q, Zamir E (2005) Update on Fuchs’ uveitis syndrome. Curr Opin Ophthalmol 16:356–363PubMedCrossRef
3.
4.
Zurück zum Zitat Rothova A, La Hey E, Baarsma GS, Breebaart AC (1994) Iris nodules in Fuchs’ heterochromic uveitis. Am J Ophthalmol 118:338–342PubMedCrossRef Rothova A, La Hey E, Baarsma GS, Breebaart AC (1994) Iris nodules in Fuchs’ heterochromic uveitis. Am J Ophthalmol 118:338–342PubMedCrossRef
5.
Zurück zum Zitat Tran VT, Auer C, Guex-Crosier Y et al (1994) Epidemiological characteristics of uveitis in Switzerland. Int Ophthalmol 18:293–298PubMedCrossRef Tran VT, Auer C, Guex-Crosier Y et al (1994) Epidemiological characteristics of uveitis in Switzerland. Int Ophthalmol 18:293–298PubMedCrossRef
6.
Zurück zum Zitat Jakob E, Reuland MS, Mackensen F et al (2009) Uveitis subtypes in a german interdisciplinary uveitis center–analysis of 1916 patients. J Rheumatol 36:127–136. doi:10.3899/jrheum.080102 PubMed Jakob E, Reuland MS, Mackensen F et al (2009) Uveitis subtypes in a german interdisciplinary uveitis center–analysis of 1916 patients. J Rheumatol 36:127–136. doi:10.​3899/​jrheum.​080102 PubMed
9.
Zurück zum Zitat Soylu M, Ozdemir G, Anli A (1997) Pediatric uveitis in southern Turkey. Ocul Immunol Inflamm 5:197–202PubMedCrossRef Soylu M, Ozdemir G, Anli A (1997) Pediatric uveitis in southern Turkey. Ocul Immunol Inflamm 5:197–202PubMedCrossRef
10.
Zurück zum Zitat Kadayifçilar S, Eldem B, Tumer B (2003) Uveitis in childhood. J Pediatr Ophthalmol Strabismus 40:335–340PubMed Kadayifçilar S, Eldem B, Tumer B (2003) Uveitis in childhood. J Pediatr Ophthalmol Strabismus 40:335–340PubMed
12.
Zurück zum Zitat Kimura SJ (1978) Fuchs’ syndrome of heterochromic cyclitis in brown-eyed patients. Trans Am Ophthalmol Soc 76:76–89PubMedCentralPubMed Kimura SJ (1978) Fuchs’ syndrome of heterochromic cyclitis in brown-eyed patients. Trans Am Ophthalmol Soc 76:76–89PubMedCentralPubMed
13.
15.
Zurück zum Zitat Schwab IR (1991) The epidemiologic association of Fuchs’ heterochromic iridocyclitis and ocular toxoplasmosis. Am J Ophthalmol 111:356–362PubMedCrossRef Schwab IR (1991) The epidemiologic association of Fuchs’ heterochromic iridocyclitis and ocular toxoplasmosis. Am J Ophthalmol 111:356–362PubMedCrossRef
16.
Zurück zum Zitat La Hey E, Rothova A, Baarsma GS et al (1992) Fuchs’ heterochromic iridocyclitis is not associated with ocular toxoplasmosis. Arch Ophthalmol 110:806–811PubMedCrossRef La Hey E, Rothova A, Baarsma GS et al (1992) Fuchs’ heterochromic iridocyclitis is not associated with ocular toxoplasmosis. Arch Ophthalmol 110:806–811PubMedCrossRef
20.
Zurück zum Zitat Ruokonen PC, Metzner S, Ucer A et al (2010) Intraocular antibody synthesis against rubella virus and other microorganisms in Fuchs’ heterochromic cyclitis. Graefes Arch Clin Exp Ophthalmol 248:565–571. doi:10.1007/s00417-009-1239-7 PubMedCrossRef Ruokonen PC, Metzner S, Ucer A et al (2010) Intraocular antibody synthesis against rubella virus and other microorganisms in Fuchs’ heterochromic cyclitis. Graefes Arch Clin Exp Ophthalmol 248:565–571. doi:10.​1007/​s00417-009-1239-7 PubMedCrossRef
23.
Zurück zum Zitat Liesegang TJ (1982) Clinical features and prognosis in Fuchs’ uveitis syndrome. Arch Ophthalmol 100:1622–1626PubMedCrossRef Liesegang TJ (1982) Clinical features and prognosis in Fuchs’ uveitis syndrome. Arch Ophthalmol 100:1622–1626PubMedCrossRef
24.
Zurück zum Zitat Jabs DA, Nussenblatt RB, Rosenbaum JT, Standardization of Uveitis Nomenclature (SUN) Working Group (2005) Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol 140:509–516. doi:10.1016/j.ajo.2005.03.057 CrossRef Jabs DA, Nussenblatt RB, Rosenbaum JT, Standardization of Uveitis Nomenclature (SUN) Working Group (2005) Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol 140:509–516. doi:10.​1016/​j.​ajo.​2005.​03.​057 CrossRef
26.
Zurück zum Zitat Heinz C, Koch JM, Zurek-Imhoff B, Heiligenhaus A (2009) Prevalence of uveitic secondary glaucoma and success of nonsurgical treatment in adults and children in a tertiary referral center. Ocul Immunol Inflamm 17:243–248. doi:10.1080/09273940902913035 PubMedCrossRef Heinz C, Koch JM, Zurek-Imhoff B, Heiligenhaus A (2009) Prevalence of uveitic secondary glaucoma and success of nonsurgical treatment in adults and children in a tertiary referral center. Ocul Immunol Inflamm 17:243–248. doi:10.​1080/​0927394090291303​5 PubMedCrossRef
27.
Zurück zum Zitat Heinz C, Mingels A, Goebel C et al (2008) Chronic uveitis in children with and without juvenile idiopathic arthritis: differences in patient characteristics and clinical course. J Rheumatol 35:1403–1407PubMed Heinz C, Mingels A, Goebel C et al (2008) Chronic uveitis in children with and without juvenile idiopathic arthritis: differences in patient characteristics and clinical course. J Rheumatol 35:1403–1407PubMed
29.
Zurück zum Zitat Smith JR, Cunningham ET (2002) Atypical presentations of ocular toxoplasmosis. Curr Opin Ophthalmol 13:387–392PubMedCrossRef Smith JR, Cunningham ET (2002) Atypical presentations of ocular toxoplasmosis. Curr Opin Ophthalmol 13:387–392PubMedCrossRef
Metadaten
Titel
Clinical manifestation of Fuchs uveitis syndrome in childhood
verfasst von
Christoph Tappeiner
Jens Dreesbach
Martin Roesel
Carsten Heinz
Arnd Heiligenhaus
Publikationsdatum
01.07.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
Graefe's Archive for Clinical and Experimental Ophthalmology / Ausgabe 7/2015
Print ISSN: 0721-832X
Elektronische ISSN: 1435-702X
DOI
https://doi.org/10.1007/s00417-015-2960-z

Weitere Artikel der Ausgabe 7/2015

Graefe's Archive for Clinical and Experimental Ophthalmology 7/2015 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Ophthalmika in der Schwangerschaft

Die Verwendung von Ophthalmika in der Schwangerschaft und Stillzeit stellt immer eine Off-label-Anwendung dar. Ein Einsatz von Arzneimitteln muss daher besonders sorgfältig auf sein Risiko-Nutzen-Verhältnis bewertet werden. In der vorliegenden …

Operative Therapie und Keimnachweis bei endogener Endophthalmitis

Vitrektomie Originalie

Die endogene Endophthalmitis ist eine hämatogen fortgeleitete, bakterielle oder fungale Infektion, die über choroidale oder retinale Gefäße in den Augapfel eingeschwemmt wird [ 1 – 3 ]. Von dort infiltrieren die Keime in die Netzhaut, den …

Bakterielle endogene Endophthalmitis

Vitrektomie Leitthema

Eine endogene Endophthalmitis stellt einen ophthalmologischen Notfall dar, der umgehender Diagnostik und Therapie bedarf. Es sollte mit geeigneten Methoden, wie beispielsweise dem Freiburger Endophthalmitis-Set, ein Keimnachweis erfolgen. Bei der …

So erreichen Sie eine bestmögliche Wundheilung der Kornea

Die bestmögliche Wundheilung der Kornea, insbesondere ohne die Ausbildung von lichtstreuenden Narben, ist oberstes Gebot, um einer dauerhaften Schädigung der Hornhaut frühzeitig entgegenzuwirken und die Funktion des Auges zu erhalten.   

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.